Functional magnetic resonance imaging in oncology for diagnosis and therapy monitoring

Molecular Cancer Therapeutics

Volumn 2, Issue 4, 2003, Pages 419-426

  Knopp, Michael V ^a,b   Von Tengg Kobligk, Hendrik ^a   Choyke, Peter L ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; GADOLINIUM PENTETATE;

BIOLOGICAL MODEL; BONE TUMOR; BREAST TUMOR; MAMMOGRAPHY; METHODOLOGY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW;

BONE NEOPLASMS; BREAST NEOPLASMS; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 1542682511     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (38)

1. Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., van Glabbeke, M., van Oosterom, T., Christian, M., et al. New guidelines to evaluate the response treatment in solid tumors. J. Natl. Cancer Inst. (Bethesda), 92: 205-216, 2000.
2. Evelhoch, J. L. Key factors in the acquisition of contrast kinetic data for oncology. J. Magn. Reson. Imaging, 10: 254-259, 1999.
3. Tofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., Larsson, H. B., Lee, T. Y., Mayr, N. A., Parker, G. J., et al.Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging, 10: 223-232, 1999.
4. Carmeliet, P., and Jain, R. K. Angiogenesis in cancer and other diseases. Nature (Lond.), 407: 249-257, 2000.
5. Padhani, A. R., and Husband, J. E. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin. Radiol., 56: 607-620, 2001.
6. Knopp, M. V., Giesel, F. L., Marcos, H., Tengg-Kobligk, H., and Choyke, P. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top. Magn. Reson. Imaging, 12: 301-308, 2001.
7. Cooper, R. A., Carrington, B. M., Loncaster, J. A., Todd, S. M., Davidson, S. E., Logue, J. P., Luthra, A. D., Jones, A. P., Stratford, I., Hunter, R. D., et al. Tumor oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother. Oncol., 57: 53-59, 2000.
8. Knopp, M. V., Weiss, E., Sinn, H. P., Mattern, J., Junkermann, H., Radeleff, J., Magener, A., Brix, D., Delorme, S., Zuna, I., et al. Pathophysiologic basis of contrast enhancement in breast tumors. J. Magn. Reson. Imaging, 10: 260-266, 1999.
9. Mayr, N. A., Hawighorst, H., Yuh, W. T., Essig, M., Magnotta, V. A., and Knopp, M. V. MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome. J. Magn. Reson. Imaging, 10: 267-276, 1999.
10. Fanelli, M., Locopo, N., Gattuso, D., and Gasparini, G. Assessment of tumor vascularization: immunohistochemical and non-invasive methods. Int. J. Biol. Markers, 14: 218-231, 1999.
11. Taylor, J. S., Tofts, P. S., Port, R., Evelhoch, J. L., Knopp, M., Reddick, W. E., Runge, V. M., and Mayr, N. MR imaging of tumor microcirculation: promise for the new millennium. J. Magn. Reson. Imaging, 10:903-907, 1999.
12. Parker, G. J., Tofts, P. S. Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging. Top. Magn. Reson. Imaging, 10: 130-142, 1999.
13. Kuhl, C. K., and Schild, H. H. Dynamic image interpretation of MRI of the breast. J. Magn. Reson. Imaging, 12: 965-974, 2000.
14. Knopp, M. V., Brix, G., Junkermann, H. J., and Sinn, H. P. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn. Reson. Imaging Clin. N. Am., 2: 633-658, 1994.
15. Tofts, P. S., and Berkowitz, B. A. Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. Magn. Reson. Imaging, 12: 81-91, 1994.
16. Brix, G., Schreiber, W., Hoffmann, U., Guckel, F., Hawighorst, H., and Knopp, M. V. Methodological approaches to quantitative evaluation of microcirculation in tissues with dynamic magnetic resonance tomography. Radiologe, 37: 470-480, 1997.
17. Knopp, M. V., von Tengg-Kobligk, H., Floemer, F., and Schoenberg, S. O. Contrast agents for MRA: future directions. J. Magn. Reson. Imaging, 10: 314-316, 1999.
18. Runge, V. M. Safety of magnetic resonance contrast media. Top. Magn. Reson. Imaging, 12: 309-314, 2001.
19. Shellock, F. G., and Kanal, E. Safety of magnetic resonance imaging contrast agents. J. Magn. Reson. Imaging, 10: 477-484, 1999.
20. Runge, V. M., and Knopp, M. V. Off-label use and reimbursement of contrast media in MR. J. Magn. Reson. Imaging, 10: 489-495, 1999.
21. Runge, V. M. Trends in contrast media research. Investig. Radiol., 36:688-691, 2001.
22. Heywang, K. S., Viehweg, P., Heinig, A., and Kuchler, C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur. J. Radiol., 24: 94-108, 1997.
23. Harms, S. E., Flamig, D. P., Evans, W. P., Harries, S. A., and Brown, S. MR imaging of the breast: current status and future potential. Am. J. Roentgenol., 163: 1039-1047, 1994.
24. Kaiser, W. A., and Mittelmeier, O. [MR mammography in patients at risk]. Rofo. Fortschr. Geb. Rontgenstr. Neuen. Bildgeb. Verfahr., 156:576-581, 1992.
25. Wong, E. T., Jackson, E. F., Hess, K. R., Schomer, D. F., Hazle, J. D., Kyritsis, A. P., Jaeckle, K. A., Yung, W. K., Levin, V. A., and Leeds, N. E. Correlation between dynamic MRI and outcome in patients with malignant gliomas. Neurology, 50: 777-781, 1998.
26. Moehler, T. M., Hawighorst, H., Neben, K., Egerer, G., Hillengass, J., Max, R., Benner, A., Ho, A. D., van Kaick, G., and Goldschmidt, H. Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int. J. Cancer, 93: 862-868, 2001.
27. Fletcher, B. D., Hanna, S. L., Fairclough, D. L., and Gronemeyer, S. A. Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology, 184: 243-248, 1992.
28. Bonnerot, V., Charpentier, A., Frouin, F., Kalifa, C., Vanel, D., and Di Paola, R. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Investig. Radiol., 27: 847-855, 1992.
29. Viehweg, P., Lampe, D., Buchmann, J., and Heywang-Kobrunner, S. H. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging. MAGMA, 11: 129-137, 2000.
30. Padhani, A. R., Gapinski, C. J., Macvicar, D. A., Parker, G. J., Suckling, J., Revell, P. B., Leach, M. O., Dearnaley, D. P., and Husband, J. E. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumor stage, histological grade and PSA. Clin. Radiol., 55: 99-109, 2000.
31. Devries, A. F., Griebel, J., Kremser, C., Judmaier, W., Gneiting, T., Kreczy, A., Ofner, D., Pfeiffer, K. P., Brix, G., and Lukas, P. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res., 61: 2513-2516, 2001.
32. Anderson, H., Price, P., Blomley, M., Leach, M. O., and Workman, P. Measuring changes in human tumor vasculature in response to therapy using functional imaging techniques. Br. J. Cancer, 85: 1085-1093, 2001.
33. Mundhenke, C., Thomas, J. P., Wilding, G., Lee, F. T., Kelzc, F., Chappell, R., Neider, R., Sebree, L. A., and Friedl, A. Tissue examination to monitor antiangiogenic therapy: a Phase I clinical trial with endostatin. Clin. Cancer Res., 7: 3366-3374, 2001.
34. Fenton, B. M., Beauchamp, B. K., Paoni, S. F., Okunieff, P., and Ding, I. Characterization of the effects of antiangiogenic agents on tumor pathophysiology. Am. J. Clin. Oncol., 24: 453-457, 2001.
35. Fuss, M., Wenz, F., Essig, M., Muenter, M., Debus, J., Herman, T. S., and Wannenmacher, M. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 51: 478-482, 2001.
36. Mayr, N. A., Yuh, W. T., Arnholt, J. C., Ehrhardt, J. C., Sorosky, J. I., Magnotta, V. A., Berbaum, K. S., Zhen, W., Paulino, A. C., Oberley, L. W., et al. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J. Magn. Reson. Imaging, 12: 1027-1033, 2000.
37. Heywang, K., Schlegel, A., Beck, R., Wendt, T., Kellner, W., Lommatzsch, B., Untch, M., and Nathrath, W. B. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J. Comput. Assisted Tomogr., 17: 891-900, 1993.
38. Gong, Q. Y., Brunt, J. N., Romaniuk, C. S., Oakley, J. P., Tan, L. T., Roberts, N., Whitehouse, G. H., and Jones, B. Contrast enhanced dynamic MRI of cervical carcinoma during radiotherapy: early prediction of tumor regression rate. Br. J. Radiol., 72: 1177-1184, 1999.